limestone has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Cheng, Y; He, C; He, X; Lee, RJ; Li, M; Lu, Y; Wu, S; Xiang, G; Yang, T; You, J; Zhang, X; Zhao, P | 1 |
| Chen, Y; He, C; Lee, RJ; Li, M; Lu, Y; Wang, Y; Xiang, G; Yang, T; You, J; Zhang, X; Zhao, P | 1 |
2 other study(ies) available for limestone and Hepatocellular Carcinoma
| Article | Year |
|---|---|
MiR-375 delivered by lipid-coated doxorubicin-calcium carbonate nanoparticles overcomes chemoresistance in hepatocellular carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Calcium Carbonate; Carcinoma, Hepatocellular; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Drug Resistance, Neoplasm; Hep G2 Cells; Humans; Lipids; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Nanoparticles | 2017 |
Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Topics: Animals; Calcium Carbonate; Carcinoma, Hepatocellular; Coated Materials, Biocompatible; Delayed-Action Preparations; Hep G2 Cells; Humans; Lipids; Liver Neoplasms; Mice; Mice, Nude; MicroRNAs; Nanoparticles; Sorafenib; Xenograft Model Antitumor Assays | 2018 |